Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices traded up today One out of the three major indices traded up today The three major indices are trading lower today with the

Dow Jones Industrial Average

(

TST Recommends

^DJI

) trading up 13 points (0.1%) at 16,818 as of Monday, Oct. 27, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,318 issues advancing vs. 1,749 declining with 148 unchanged.

The Services sector as a whole closed the day down 0.2% versus the S&P 500, which was down 0.2%. Top gainers within the Services sector included

Point 360

(

PTSX

), up 11.4%,

Bioanalytical Systems

(

BASI

), up 3.5%,

Tiger Media

(

IDI

), up 11.9%,

Books-A-Million

(

BAMM

), up 4.7% and

Educational Development

(

EDUC

), up 1.6%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the sector higher today:

Books-A-Million

(

BAMM

) is one of the companies that pushed the Services sector higher today. Books-A-Million was up $0.07 (4.7%) to $1.56 on light volume. Throughout the day, 8,483 shares of Books-A-Million exchanged hands as compared to its average daily volume of 14,600 shares. The stock ranged in a price between $1.50-$1.56 after having opened the day at $1.50 as compared to the previous trading day's close of $1.49.

Books-A-Million, Inc. operates as a book retailer primarily in the eastern United States. It operates in three segments: Retail Trade, Electronic Commerce Trade, and Real Estate Development and Management. Books-A-Million has a market cap of $23.8 million and is part of the transportation industry. Shares are down 30.3% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate Books-A-Million a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Books-A-Million as a

sell

. The company's weaknesses can be seen in multiple areas, such as its poor profit margins, generally disappointing historical performance in the stock itself and generally high debt management risk.

Highlights from TheStreet Ratings analysis on BAMM go as follows:

  • The gross profit margin for BOOKS-A-MILLION INC is currently lower than what is desirable, coming in at 28.63%. Regardless of BAMM's low profit margin, it has managed to increase from the same period last year. Despite the mixed results of the gross profit margin, BAMM's net profit margin of -2.78% significantly underperformed when compared to the industry average.
  • BAMM's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 35.35%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much attention to the earnings improvements the company has managed to achieve over the last quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • BAMM's debt-to-equity ratio of 0.63 is somewhat low overall, but it is high when compared to the industry average, implying that the management of the debt levels should be evaluated further. Even though the debt-to-equity ratio shows mixed results, the company's quick ratio of 0.06 is very low and demonstrates very weak liquidity.
  • The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. Compared to other companies in the Specialty Retail industry and the overall market, BOOKS-A-MILLION INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • BOOKS-A-MILLION INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has not demonstrated a clear trend in earnings over the past 2 years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, BOOKS-A-MILLION INC swung to a loss, reporting -$0.52 versus $0.15 in the prior year.

You can view the full analysis from the report here:

Books-A-Million Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close,

Tiger Media

(

IDI

) was up $0.06 (11.9%) to $0.60 on light volume. Throughout the day, 8,700 shares of Tiger Media exchanged hands as compared to its average daily volume of 30,500 shares. The stock ranged in a price between $0.55-$0.61 after having opened the day at $0.57 as compared to the previous trading day's close of $0.54.

Tiger Media, Inc., a multi-platform media company, provides advertising services in the out-of-home advertising industry in the People's Republic of China. Tiger Media has a market cap of $19.2 million and is part of the transportation industry. Shares are down 64.5% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate Tiger Media a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Tiger Media as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on IDI go as follows:

  • TIGER MEDIA INC reported flat earnings per share in the most recent quarter. The company has suffered a declining pattern earnings per share over the past two years. During the past fiscal year, TIGER MEDIA INC reported poor results of -$0.12 versus -$0.03 in the prior year.
  • IDI's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 64.94%, which is also worse than the performance of the S&P 500 Index. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • The company, on the basis of net income growth from the same quarter one year ago, has underperformed when compared to that of the S&P 500 and greatly underperformed compared to the Media industry average. The net income increased by 1.9% when compared to the same quarter one year prior, going from -$0.88 million to -$0.86 million.
  • Compared to other companies in the Media industry and the overall market, TIGER MEDIA INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • IDI has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 2.75, which clearly demonstrates the ability to cover short-term cash needs.

You can view the full analysis from the report here:

Tiger Media Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Bioanalytical Systems

(

BASI

) was another company that pushed the Services sector higher today. Bioanalytical Systems was up $0.08 (3.5%) to $2.38 on light volume. Throughout the day, 800 shares of Bioanalytical Systems exchanged hands as compared to its average daily volume of 6,800 shares. The stock ranged in a price between $2.16-$2.40 after having opened the day at $2.20 as compared to the previous trading day's close of $2.30.

Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. Bioanalytical Systems has a market cap of $19.3 million and is part of the transportation industry. Shares are down 11.8% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate Bioanalytical Systems a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Bioanalytical Systems as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow.

Highlights from TheStreet Ratings analysis on BASI go as follows:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Life Sciences Tools & Services industry. The net income has significantly decreased by 62.7% when compared to the same quarter one year ago, falling from $0.58 million to $0.22 million.
  • Net operating cash flow has significantly decreased to $0.21 million or 75.43% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Life Sciences Tools & Services industry and the overall market, BIOANALYTICAL SYSTEMS INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • BIOANALYTICAL SYSTEMS INC has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has not demonstrated a clear trend in earnings over the past 2 years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, BIOANALYTICAL SYSTEMS INC turned its bottom line around by earning $0.09 versus -$0.87 in the prior year.
  • 39.46% is the gross profit margin for BIOANALYTICAL SYSTEMS INC which we consider to be strong. Regardless of BASI's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 3.56% trails the industry average.

You can view the full analysis from the report here:

Bioanalytical Systems Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.